Dr. Chen Discusses Racial Disparities in CTCL

Video

Pei-Ling Chen, MD, PhD, discusses epidemiology and racial disparities in CTCL.

Pei-Ling Chen, MD, PhD, is a member of the Pathology and Cutaneous Oncology Departments at Moffitt Cancer Center and a member of the Moffitt Cutaneous Lymphoma Multidisciplinary Clinic specializing in the research and treatment of cutaneous T-cell lymphoma (CTCL).

Men are more likely to develop CTCL than women, Chen explains. The median age at diagnosis is 55 to 60 years. and risk increases with age.

Black patients have a higher incidence rate of CTCL, younger age of onset, higher disease burden, and inferior survival compared with their White counterparts. Furthmore, Chen said the racial coorelates of CTCL are poorly understood and require further study.

Related Videos
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Vikram M. Narayan, MD, assistant professor, Department of Urology, Emory University School of Medicine, Winship Cancer Institute; director, Urologic Oncology, Grady Memorial Hospital
Stephen V. Liu, MD
S. Vincent Rajkumar, MD
Pashtoon Murtaza Kasi, MD, MS
Naseema Gangat, MBBS
Samilia Obeng-Gyasi, MD, MPH,
Kian-Huat Lim, MD, PhD
Saurabh Dahiya, MD, FACP, associate professor, medicine (blood and marrow transplantation and cellular therapy), Stanford University School of Medicine, clinical director, Cancer Cell Therapy, Stanford BMT and Cell Therapy Division
Muhamed Baljevic, MD